Editas prices IPO

Gene editing company Editas Medicine Inc. (NASDAQ:EDIT) raised $94.4 million in an IPO through the sale of 5.9 million shares at $16, the low end of its previously proposed range. Underwriters were Morgan Stanley, JPMorgan, Cowen and JMP Securities. ...